Clinical Trials for Lung Disease: How to Find and Participate in Research

Home / Conditions / Lung Infections / Clinical Trials for Lung Disease: How to Find and Participate in Research
Illustration for "Clinical Trials for Lung Disease: How to Find and Participate in Research" showing clinical trials for lung disease

Quick Answer: Clinical trials offer access to cutting-edge treatments while contributing to medical progress. This guide explains how to find relevant trials for asthma, COPD, pulmonary fibrosis, lung cancer, and other respiratory conditions through registries like ClinicalTrials.gov, determine eligibility, understand phases, evaluate risks and benefits, and participate safely. Current active research areas include biologics for severe asthma, antifibrotics, gene therapy, immunotherapy for lung cancer, and regenerative medicine. Participation is always voluntary, and safeguards protect participant rights.

What Are Clinical Trials?

Clinical trials are research studies involving human volunteers that evaluate new medical treatments, interventions, or diagnostic methods. They follow strict scientific protocols designed to answer specific questions about safety, effectiveness, dosing, and side effects.

For respiratory diseases, clinical trials may study:

  • New medications (novel bronchodilators, antifibrotics, biologics)
  • Medical devices (new inhalers, oxygen delivery systems, ventilators)
  • Treatment combinations (dual/triple therapies for COPD and asthma)
  • Non-pharmacological interventions (exercise programs, dietary modifications, breathing techniques)
  • Diagnostic tools (new biomarkers, imaging techniques)
  • Prevention strategies (vaccines, lifestyle interventions)

Why Participate?

| Benefit | Description |

|———|————-|

| Access to new treatments | May receive therapies not yet available to the public |

| Expert care | Close monitoring by specialized research teams |

| Contributing to science | Help advance treatments that may benefit future patients |

| Cost savings | Study-related care typically provided at no cost; some offer compensation |

| Active role | Take an active role in your healthcare and disease management |

| Comprehensive care | More frequent visits and testing than standard care |

Understanding Clinical Trial Phases

| Phase | Participants | Purpose | Success Rate to Next Phase |

|——-|————-|———|—————————|

| Phase 0 | 10-20 | Exploratory; does drug behave as expected? | N/A |

| Phase I | 20-100 | Safety; dosage range; side effects | ~70% |

| Phase II | 100-300 | Effectiveness for specific condition | ~33% |

| Phase III | 1,000-3,000+ | Compare to standard treatment; confirm efficacy | ~25-30% |

| Phase IV | Thousands | Post-approval monitoring; long-term effects; new uses | N/A (already approved) |

Most participants join Phase II or III trials, where some evidence of effectiveness already exists.

How to Find Clinical Trials

ClinicalTrials.gov

The U.S. National Library of Medicine maintains the most comprehensive database: clinicaltrials.gov

Search strategy:

  1. Enter your condition (e.g., “COPD,” “idiopathic pulmonary fibrosis,” “severe asthma”)
  2. Filter by location, recruitment status (“Recruiting”), age group
  3. Review eligibility criteria
  4. Contact the study coordinator listed

Disease-Specific Trial Resources

| Disease | Resource |

|———|———-|

| COPD | COPD Foundation: copdfoundation.org/research |

| Asthma (severe) | ALL Severe Asthma Research Program; NIH AsthmaNet |

| Pulmonary fibrosis | Pulmonary Fibrosis Foundation: pulmonaryfibrosis.org |

| Cystic fibrosis | Cystic Fibrosis Foundation: cff.org/research |

| Lung cancer | GO2 Foundation: go2foundation.org; Lung Cancer Alliance |

| General respiratory | American Lung Association: lung.org/research |

| Pulmonary hypertension | PHA Clinical Trials: phassociation.org |

Academic Medical Centers

Major centers with dedicated research programs actively recruit participants. Contact the research office at centers near you.

Physician Referral

Ask your pulmonologist about trials you might qualify for. Specialists at academic centers are most likely to know about available studies.

Understanding Eligibility Criteria

Trials have inclusion criteria (must have) and exclusion criteria (must not have) to ensure safety and scientific validity:

Common inclusion criteria:

  • Confirmed diagnosis of specific condition
  • Age range
  • Disease severity parameters (FEV1 range, oxygen needs, disease stage)
  • Specific symptoms or biomarkers
  • Ability to comply with protocol requirements

Common exclusion criteria:

  • Comorbid conditions that increase risk
  • Current use of excluded medications
  • Recent participation in another trial
  • Pregnancy or nursing
  • History of specific conditions (e.g., cancer, heart disease)
  • Geographic limitations (must live within specified distance)

Questions to Ask Before Enrolling

| Topic | Key Questions |

|——-|————–|

| Purpose | What is the study trying to find out? How will results be used? |

| Intervention | What will I receive? Is there a placebo? Can I continue current treatments? |

| Duration | How long does participation last? How many visits required? |

| Costs | What is covered by the study? What will my insurance/myself need to cover? |

| Compensation | Is there payment for participation? Travel reimbursement? |

| Risks | What side effects have been seen? What monitoring is in place? |

| Benefits | What are the potential benefits? Are they likely or theoretical? |

| Randomization | Am I guaranteed the experimental treatment, or might I receive placebo? |

| Blinding | Will I know what I’m receiving? Will my doctor know? |

| Unblinding | Can I find out my assignment if needed? Can I request active treatment? |

| Stopping rules | Under what circumstances would the trial stop? Can I withdraw? |

| Follow-up | What happens after the trial ends? Will I have access to the treatment? |

| IRB approval | Has this been reviewed by an ethics board? (Should always be yes) |

Participant Protections

Institutional Review Board (IRB)

Every clinical trial in the U.S. must be approved and monitored by an IRB, an independent ethics committee that ensures:

  • Risks are minimized and reasonable relative to potential benefits
  • Informed consent is adequate and understandable
  • Participant selection is equitable
  • Privacy and confidentiality are protected

Informed Consent

Before enrolling, you must receive and sign an informed consent document explaining:

  • Study purpose and procedures
  • Potential risks and benefits
  • Alternative treatments available
  • Your rights as a participant, including the right to withdraw at any time
  • Contact information for questions or concerns

Signing consent is not a contract: you can leave the trial at any time without penalty or loss of regular medical care.

Data Safety Monitoring Board (DSMB)

Many trials have an independent DSMB that reviews safety data periodically. If one group is clearly doing better (or worse), the DSMB can recommend stopping or modifying the trial.

Current Exciting Research Areas

| Area | Description | Target Conditions |

|——|————-|——————-|

| Biologics for asthma | Monoclonal antibodies targeting specific inflammatory pathways | Severe eosinophilic/allergic asthma |

| Antifibrotics | Medications slowing lung scarring | IPF, progressive fibrosing ILDs |

| Triple therapy for COPD | Single-inhaler combinations of LAMA+LABA+ICS | COPD |

| Lung cancer immunotherapy | Checkpoint inhibitors, CAR-T cell therapy | Non-small cell lung cancer |

| Gene therapy | Correcting defective genes; delivering therapeutic genes | CF, alpha-1 antitrypsin deficiency |

| Stem cell therapy | Regenerating damaged lung tissue | COPD, IPF |

| Microbiome research | Understanding lung/gut microbiome roles | Asthma, COPD, CF |

| Digital health | Apps, wearables, AI for monitoring and management | All respiratory conditions |

| Exacerbation prediction | Biomarkers and AI to predict and prevent flare-ups | COPD, asthma |

| Inhaled antibiotics | New formulations for resistant infections | Bronchiectasis, NTM, CF |

Key Takeaways

  • Clinical trials offer access to cutting-edge treatments before general availability
  • Participation is always voluntary, with full informed consent and right to withdraw
  • Search ClinicalTrials.gov and disease-specific organizations for relevant studies
  • Ask detailed questions about purpose, risks, benefits, costs, and your rights before enrolling
  • IRB oversight and informed consent protect participant safety and rights
  • Contributing to research helps future patients while potentially benefiting yourself
  • Your physician should support your decision to participate and coordinate care

This guide is for informational purposes. Clinical trial participation requires careful consideration and medical guidance. Never discontinue prescribed treatments to join a trial without medical supervision.

Medical Disclaimer: This article does not constitute medical advice. Consult your healthcare provider about clinical trial participation.

This article is general information and not a substitute for professional medical advice.

Sources

Editorial note: this is general health information, not medical advice. Our articles are written and checked against published guidance by our editorial team and are not reviewed by a clinician unless the article says so. If your care team has told you something different, follow their advice.

Leave a Reply

Your email address will not be published.